119 related articles for article (PubMed ID: 17255357)
1. NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome.
Gazit R; Aker M; Elboim M; Achdout H; Katz G; Wolf DG; Katzav S; Mandelboim O
Blood; 2007 May; 109(10):4306-12. PubMed ID: 17255357
[TBL] [Abstract][Full Text] [Related]
2. Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity.
Wood SM; Meeths M; Chiang SC; Bechensteen AG; Boelens JJ; Heilmann C; Horiuchi H; Rosthøj S; Rutynowska O; Winiarski J; Stow JL; Nordenskjöld M; Henter JI; Ljunggren HG; Bryceson YT
Blood; 2009 Nov; 114(19):4117-27. PubMed ID: 19704116
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.
Grier JT; Forbes LR; Monaco-Shawver L; Oshinsky J; Atkinson TP; Moody C; Pandey R; Campbell KS; Orange JS
J Clin Invest; 2012 Oct; 122(10):3769-80. PubMed ID: 23006327
[TBL] [Abstract][Full Text] [Related]
4. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.
Bryceson YT; March ME; Ljunggren HG; Long EO
Blood; 2006 Jan; 107(1):159-66. PubMed ID: 16150947
[TBL] [Abstract][Full Text] [Related]
5. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations.
Meeths M; Bryceson YT; Rudd E; Zheng C; Wood SM; Ramme K; Beutel K; Hasle H; Heilmann C; Hultenby K; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI
Pediatr Blood Cancer; 2010 Apr; 54(4):563-72. PubMed ID: 19953648
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
[TBL] [Abstract][Full Text] [Related]
8. Griscelli syndrome: characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene.
Bizario JC; Feldmann J; Castro FA; Ménasché G; Jacob CM; Cristofani L; Casella EB; Voltarelli JC; de Saint-Basile G; Espreafico EM
J Clin Immunol; 2004 Jul; 24(4):397-410. PubMed ID: 15163896
[TBL] [Abstract][Full Text] [Related]
9. Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding.
Cetica V; Hackmann Y; Grieve S; Sieni E; Ciambotti B; Coniglio ML; Pende D; Gilmour K; Romagnoli P; Griffiths GM; Aricò M
J Allergy Clin Immunol; 2015 May; 135(5):1310-8.e1. PubMed ID: 25312756
[TBL] [Abstract][Full Text] [Related]
10. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
11. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.
Della Chiesa M; Carlomagno S; Frumento G; Balsamo M; Cantoni C; Conte R; Moretta L; Moretta A; Vitale M
Blood; 2006 Dec; 108(13):4118-25. PubMed ID: 16902152
[TBL] [Abstract][Full Text] [Related]
12. Selective cross-talk among natural cytotoxicity receptors in human natural killer cells.
Augugliaro R; Parolini S; Castriconi R; Marcenaro E; Cantoni C; Nanni M; Moretta L; Moretta A; Bottino C
Eur J Immunol; 2003 May; 33(5):1235-41. PubMed ID: 12731048
[TBL] [Abstract][Full Text] [Related]
13. Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.
Mamishi S; Modarressi MH; Pourakbari B; Tamizifar B; Mahjoub F; Fahimzad A; Alyasin S; Bemanian MH; Hamidiyeh AA; Fazlollahi MR; Ashrafi MR; Isaeian A; Khotaei G; Yeganeh M; Parvaneh N
J Clin Immunol; 2008 Jul; 28(4):384-9. PubMed ID: 18350256
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.
Castriconi R; Cantoni C; Della Chiesa M; Vitale M; Marcenaro E; Conte R; Biassoni R; Bottino C; Moretta L; Moretta A
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4120-5. PubMed ID: 12646700
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the molecular defects in Rab27a, caused by RAB27A missense mutations found in patients with Griscelli syndrome.
Bahadoran P; Busca R; Chiaverini C; Westbroek W; Lambert J; Bille K; Valony G; Fukuda M; Naeyaert JM; Ortonne JP; Ballotti R
J Biol Chem; 2003 Mar; 278(13):11386-92. PubMed ID: 12531900
[TBL] [Abstract][Full Text] [Related]
16. Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2.
Vincent LM; Gilbert F; DiPace JI; Ciccone C; Markello TC; Jeong A; Dorward H; Westbroek W; Gahl WA; Bussel JB; Huizing M
Mol Genet Metab; 2010 Sep; 101(1):62-5. PubMed ID: 20591709
[TBL] [Abstract][Full Text] [Related]
17. Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L; Wang X; Pabst HF; Dutz J; Tan R
J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
[TBL] [Abstract][Full Text] [Related]
18. Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors.
Poggi A; Prevosto C; Massaro AM; Negrini S; Urbani S; Pierri I; Saccardi R; Gobbi M; Zocchi MR
J Immunol; 2005 Nov; 175(10):6352-60. PubMed ID: 16272287
[TBL] [Abstract][Full Text] [Related]
19. Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity.
Sanal O; Ersoy F; Tezcan I; Metin A; Yel L; Ménasché G; Gürgey A; Berkel I; de Saint Basile G
J Clin Immunol; 2002 Jul; 22(4):237-43. PubMed ID: 12148598
[TBL] [Abstract][Full Text] [Related]
20. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.
de Vries E; Koene HR; Vossen JM; Gratama JW; von dem Borne AE; Waaijer JL; Haraldsson A; de Haas M; van Tol MJ
Blood; 1996 Oct; 88(8):3022-7. PubMed ID: 8874200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
